1. Home
  2. MNDR vs GOVX Comparison

MNDR vs GOVX Comparison

Compare MNDR & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • GOVX
  • Stock Information
  • Founded
  • MNDR 2016
  • GOVX 2001
  • Country
  • MNDR Singapore
  • GOVX United States
  • Employees
  • MNDR N/A
  • GOVX N/A
  • Industry
  • MNDR
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNDR
  • GOVX Health Care
  • Exchange
  • MNDR Nasdaq
  • GOVX Nasdaq
  • Market Cap
  • MNDR 6.8M
  • GOVX 7.6M
  • IPO Year
  • MNDR 2024
  • GOVX N/A
  • Fundamental
  • Price
  • MNDR $1.09
  • GOVX $0.76
  • Analyst Decision
  • MNDR
  • GOVX Strong Buy
  • Analyst Count
  • MNDR 0
  • GOVX 4
  • Target Price
  • MNDR N/A
  • GOVX $10.50
  • AVG Volume (30 Days)
  • MNDR 400.3K
  • GOVX 1.2M
  • Earning Date
  • MNDR 06-16-2025
  • GOVX 07-28-2025
  • Dividend Yield
  • MNDR N/A
  • GOVX N/A
  • EPS Growth
  • MNDR N/A
  • GOVX N/A
  • EPS
  • MNDR N/A
  • GOVX N/A
  • Revenue
  • MNDR $11,600,567.00
  • GOVX $6,143,044.00
  • Revenue This Year
  • MNDR $188,831.77
  • GOVX N/A
  • Revenue Next Year
  • MNDR $76.44
  • GOVX N/A
  • P/E Ratio
  • MNDR N/A
  • GOVX N/A
  • Revenue Growth
  • MNDR 0.61
  • GOVX 1943.07
  • 52 Week Low
  • MNDR $0.84
  • GOVX $0.43
  • 52 Week High
  • MNDR $8.00
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • MNDR N/A
  • GOVX 51.62
  • Support Level
  • MNDR N/A
  • GOVX $0.66
  • Resistance Level
  • MNDR N/A
  • GOVX $0.75
  • Average True Range (ATR)
  • MNDR 0.00
  • GOVX 0.05
  • MACD
  • MNDR 0.00
  • GOVX 0.01
  • Stochastic Oscillator
  • MNDR 0.00
  • GOVX 62.30

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: